This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Myers RE , Wolf TA , Balshem AM , Ross EA , Chodak GW
Receptivity of African-American men to prostate cancer screening
Urology. 1994 Apr;43(4) :480-7
PMID: 8154068 URL: https://www.ncbi.nlm.nih.gov/pubmed/8154068
AbstractOBJECTIVE: The lifetime risk of prostate cancer among African-American men is two times higher than that of white men. Mortality from the disease is almost three times greater in African-Americans than in whites. This study assesses the receptivity of older (fifty to seventy-four years of age) African-American men (n = 86) in Chicago to periodic (annual and semiannual) prostate cancer screening. METHODS: A telephone survey conducted in January and February 1993, was used to collect data on subject sociodemographic background and medical history and to gather information on knowledge, attitudes, and beliefs about prostate cancer and screening. Univariate and multivariate analyses were carried out to identify factors associated with subject receptivity to annual and semiannual screening. RESULTS: Logistic regression analyses revealed that receptivity to annual and semiannual (every six months) examination is strongly associated with the degree to which screening is perceived as a salient and coherent (i.e., important, effective, and convenient) preventive health behavior. An additional factor independently associated with willingness to go through semiannual screening was subjects' awareness that African-American men are at increased risk for prostate cancer compared to white men. CONCLUSIONS: Findings from this study suggest that African-American men are willing to undergo prostate screening and are more receptive to annual than semiannual screening. Participation in screening may be facilitated by the provision of health education messages that emphasize the salience and coherence of early detection and elevated population risk.
NotesMyers, R E Wolf, T A Balshem, A M Ross, E A Chodak, G W eng CA06927/CA/NCI NIH HHS/ CA34856-06/CA/NCI NIH HHS/ RR05895/RR/NCRR NIH HHS/ Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Urology. 1994 Apr;43(4):480-7.